the last 8 years for me............
What I see as being different is that we now have hard high level evidence of the products performance - yes we have had a large amount of 'clinical information' from many case studies and series (like the 10 000+ occasions of the technology used in patients of cardiocel)...and yes we have had the oportunity to sell our story at medical conferences........but the current trial is just that - a formalised clinical trial which provides robust results that the scientific world pays real attention to. thats the difference this time (in my opinion).
The next 6 - 12 months will hopefully see the results of the first formal trial of the new product (valve) announced, and published in the scientific literature. That will be the difference this time.
- Forums
- ASX - By Stock
- AVR
- I like to suture
AVR
anteris technologies global corp.
Add to My Watchlist
3.43%
!
$5.91

I like to suture, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
-0.210(3.43%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$6.01 | $6.08 | $5.85 | $44.71K | 7.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 857 | $5.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 260 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 1000 | 5.610 |
2 | 3500 | 5.600 |
2 | 3736 | 5.500 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 260 | 1 |
6.180 | 50 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
Last trade - 15.51pm 26/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online